Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score (Q34548664)

2 August 2017

Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score (English)

1 reference

2 August 2017

Almarie Uys

1

1 reference

PubMed ID

15197637

2 August 2017

Bernardo L Rapoport

series ordinal

2

1 reference

PubMed ID

15197637

2 August 2017

Ronald Anderson

series ordinal

3

1 reference

2 August 2017

9 June 2004

1 reference

Supportive Care in Cancer

2 August 2017

1 reference

2 August 2017

12

1 reference

2 August 2017

8

1 reference

2 August 2017

555-560

1 reference

https://scigraph.springernature.com/pub.10.1007/s00520-004-0614-5

2 August 2017

0 references

cites work

Varicella-zoster infection in adult cancer patients. A population study

1 reference

12 December 2020

Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule

1 reference

12 December 2020

From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel

1 reference

12 December 2020

Multinational cooperation in trials and guidelines dealing with febrile neutropenia

1 reference

12 December 2020

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

1 reference

12 December 2020

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

12 December 2020

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

1 reference

12 December 2020

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

1 reference

12 December 2020

Empiric antibiotic therapy for granulocytopenic cancer patients

1 reference

12 December 2020

10.1007/S00520-004-0614-5

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

15197637